These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 17143989

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Disabling pansclerotic morphea: clinical presentation in two adults.
    Maragh SH, Davis MD, Bruce AJ, Nelson AM.
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 1):S115-9. PubMed ID: 16021158
    [Abstract] [Full Text] [Related]

  • 3. Disabling pansclerotic morphea of childhood poses a high risk of chronic ulceration of the skin and squamous cell carcinoma.
    Wollina U, Buslau M, Heinig B, Petrov I, Unger E, Kyriopoulou E, Koch A, Köstler E, Schönlebe J, Haroske G, Doede T, Pramatarov K.
    Int J Low Extrem Wounds; 2007 Dec; 6(4):291-8. PubMed ID: 18048875
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bosentan as a rescue therapy in scleroderma refractory digital ulcers.
    Chamaillard M, Heliot-Hosten I, Constans J, Taïeb A.
    Arch Dermatol; 2007 Jan; 143(1):125-6. PubMed ID: 17224564
    [No Abstract] [Full Text] [Related]

  • 7. Bosentan for digital ulcers in patients with systemic sclerosis: a prospective 3-year followup study.
    Tsifetaki N, Botzoris V, Alamanos Y, Argyriou E, Zioga A, Drosos AA.
    J Rheumatol; 2009 Jul; 36(7):1550-2. PubMed ID: 19567637
    [No Abstract] [Full Text] [Related]

  • 8. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
    Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E, Rich E, Carpentier P, Molitor J, Seibold JR, Hsu V, Guillevin L, Chatterjee S, Peter HH, Coppock J, Herrick A, Merkel PA, Simms R, Denton CP, Furst D, Nguyen N, Gaitonde M, Black C.
    Arthritis Rheum; 2004 Dec; 50(12):3985-93. PubMed ID: 15593188
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Systemic lupus erythematosus, complicated with refractory skin ulcers, treated successfully with bosentan.
    Suzuki E, Kyozuka H, Nishida T, Kanno T, Ohira H.
    Mod Rheumatol; 2009 Dec; 19(4):447-51. PubMed ID: 19504167
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Resolution of severe digital ulceration during a course of Bosentan therapy.
    Snyder MJ, Jacobs MR, Grau RG, Wilkes DS, Knox KS.
    Ann Intern Med; 2005 May 03; 142(9):802-3. PubMed ID: 15867420
    [No Abstract] [Full Text] [Related]

  • 14. Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangrene.
    Ichimura Y, Asano Y, Hatano M, Tamaki Z, Takekoshi T, Kogure A, Tomita M, Kawashima T, Miyazaki M, Taniguchi T, Takahashi T, Mitsui H, Sugaya M, Yao A, Kinugawa K, Sato S.
    Mod Rheumatol; 2011 Oct 03; 21(5):548-52. PubMed ID: 21547701
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.
    Soh HJ, Samuel C, Heaton V, Renton WD, Cox A, Munro J.
    Rheumatol Int; 2019 May 03; 39(5):933-941. PubMed ID: 30838436
    [Abstract] [Full Text] [Related]

  • 18. Digital ulcers in scleroderma patients: A retrospective observational study.
    De Cata A, Inglese M, Molinaro F, De Cosmo S, Rubino R, Bernal M, Mazzoccoli G.
    Int J Immunopathol Pharmacol; 2016 Jun 03; 29(2):180-7. PubMed ID: 26684622
    [Abstract] [Full Text] [Related]

  • 19. Disabling pansclerotic morphoea of childhood.
    Jamalpur I, Mogili HR, Koratala A.
    BMJ Case Rep; 2018 Feb 17; 2018():. PubMed ID: 29455178
    [Abstract] [Full Text] [Related]

  • 20. [Severe course of a mutilating pansclerotic circumscribed scleroderma in childhood. Clinical aspects and therapy].
    Stücker M, Schreiber D, Gruss C, Freitag M, von Kobyletzki G, Kerscher M, Altmeyer P.
    Hautarzt; 1999 Feb 17; 50(2):131-5. PubMed ID: 10097957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.